DOI: 10.1016/j.addr.2008.08.005. Active targeting schemes for nanoparticle systems in cancer therapeutics

Active targeting schemes for nanoparticle systems in cancer therapeutics

10.1016/j.addr.2008.08.005

Crossref journal-article

Elsevier BV

Advanced Drug Delivery Reviews (78)

Bibliography

Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008). Active targeting schemes for nanoparticle systems in cancer therapeutics. Advanced Drug Delivery Reviews, 60(15), 1615â1626.

Authors 3

James D. Byrne (first)
Tania Betancourt (additional)
Lisa Brannon-Peppas (additional)

References 143 Referenced 1,447

10.1016/j.addr.2004.02.014 / Adv. Drug Deliv. Rev. / Nanoparticle and targeted systems for cancer therapy by Brannon-Peppas (2004)
10.1016/j.urolonc.2007.03.015 / Urol. Oncol. / Nanoparticles for drug delivery in cancer treatment by Haley (2008)
10.1158/0008-5472.CAN-04-3921 / Cancer Res. / Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer by Kukowska-Latallo (2005)
10.1021/bc034125f / Bioconjug. Chem. / Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery by Bellocq (2003)
10.2217/17435889.2.2.219 / Nanomed / Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation by Betancourt (2007)
10.1007/s11095-006-9223-y / Pharm. Res. / Functionalized micellar systems for cancer targeted drug delivery by Sutton (2007)
10.1016/S1359-6446(05)03575-0 / Drug Discov. Today / PEGylation, successful approach to drug delivery by Veronese (2005)
10.1593/neo.05769 / Neoplasia / Nanoparticle imaging of integrins on tumor cells by Montet (2006)
10.1039/b413435d / Chem. Commun. (Camb.) / Selective attachment and release of a chemotherapeutic agent from the interior of a protein cage architecture by Flenniken (2005)
10.2147/nano.2006.1.2.149 / Int. J. Nanomed. / Immunonanoshells for targeted photothermal ablation of tumor cells by Lowery (2006)
10.1073/pnas.0502680102 / Proc. Natl. Acad. Sci. U. S. A. / Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction by Kam (2005)
10.1016/S0378-5173(03)00132-7 / Int. J. Pharm. / A PEGylated dendritic nanoparticulate carrier of fluorouracil by Bhadra (2003)
10.1023/A:1018924219540 / Pharm. Res. / Influence of poly(DL-lactide) nanocapsules on the biliary clearance and enterohepatic circulation of indomethacin in the rabbit by Fawaz (1993)
10.1016/S0927-7765(99)00156-3 / Colloids Surf., B Biointerfaces / ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption by Gref (2000)
10.1016/S0169-409X(02)00226-0 / Adv. Drug Deliv. Rev. / PEGylated nanoparticles for biological and pharmaceutical applications by Otsuka (2003)
10.1038/sj.clpt.6100400 / Clin. Pharmacol. Ther. / Nanoparticles in medicine: therapeutic applications and developments by Zhang (2008)
{'issue': '4', 'key': '10.1016/j.addr.2008.08.005_bib17', 'first-page': '209', 'article-title': 'New developments in angiogenesis: a major mechanism for tumor growth and target for therapy', 'volume': '4', 'author': 'Jones', 'year': '1998', 'journal-title': 'Cancer J. Sci. Am.'} / Cancer J. Sci. Am. / New developments in angiogenesis: a major mechanism for tumor growth and target for therapy by Jones (1998)
10.1016/S0169-409X(98)00003-9 / Adv. Drug Deliv. Rev. / Control of tumour vascular permeability by Baban (1998)
10.1073/pnas.95.8.4607 / Proc. Natl. Acad. Sci. U. S. A. / Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment by Hobbs (1998)
10.1016/S0009-9260(66)80052-1 / Clin. Radiol. / Microcirculation of tumors. II. The supervascularized state of irradiated regressing tumors by Rubin (1966)
10.1007/BF00409698 / J. Cancer Res. Clin. Oncol. / Vascularization of tumors: a review by Shubik (1982)
10.1084/jem.133.2.275 / J. Exp. Med. / Isolation of a tumor factor responsible for angiogenesis by Folkman (1971)
10.1002/ijc.11108 / Int. J. Cancer / Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels by Krasnici (2003)
10.1046/j.1523-1747.2003.12057.x / J. Invest. Dermatol. / Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a “humanized” SCID mouse model by Kunstfeld (2003)
{'issue': '21', 'key': '10.1016/j.addr.2008.08.005_bib25', 'first-page': '6132', 'article-title': 'Increased exposure of anionic phospholipids on the surface of tumor blood vessels', 'volume': '62', 'author': 'Ran', 'year': '2002', 'journal-title': 'Cancer Res.'} / Cancer Res. / Increased exposure of anionic phospholipids on the surface of tumor blood vessels by Ran (2002)
10.1172/JCI965 / J. Clin. Invest. / Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice by Thurston (1998)
10.1158/0008-5472.CAN-05-4199 / Cancer Res. / Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models by Kirpotin (2006)
10.1016/j.ijpharm.2007.04.037 / Int. J. Pharm. / Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes by Hatakeyama (2007)
10.1016/S0083-6729(00)60022-5 / Vitam. Horm. / Liposome targeting to tumors using vitamin and growth factor receptors by Drummond (2000)
10.1002/ijc.10242 / Int. J. Cancer. / Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer by Iinuma (2002)
10.1016/j.ijpharm.2006.08.039 / Int. J. Pharm. / Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells by Kobayashi (2007)
{'issue': '15', 'key': '10.1016/j.addr.2008.08.005_bib32', 'first-page': '3320', 'article-title': 'In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma', 'volume': '58', 'author': 'Lopes de Menezes', 'year': '1998', 'journal-title': 'Cancer Res.'} / Cancer Res. / In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma by Lopes de Menezes (1998)
10.1248/bpb.30.972 / Biol. Pharm. Bull. / In vitro efficacy of a sterically stabilized immunoliposomes targeted to membrane type 1 matrix metalloproteinase (MT1-MMP) by Atobe (2007)
10.1016/S0014-5793(97)00905-8 / FEBS Lett. / Immunoliposomes bearing polyethyleneglycol-coupled Fab′ fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo by Maruyama (1997)
10.1016/j.jconrel.2007.11.005 / J. Control. Release / Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab′ fragments and single chain Fv by Cheng (2008)
10.1158/1078-0432.CCR-03-0041 / Clin. Cancer Res. / Improved therapeutic responses in a xenograft model of human B lymphoma (Namalwa) for liposomal vincristine versus liposomal doxorubicin targeted via anti-CD19 IgG2a or Fab′ fragments by Sapra (2004)
{'issue': '12', 'key': '10.1016/j.addr.2008.08.005_bib37', 'first-page': '4750', 'article-title': 'High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules', 'volume': '61', 'author': 'Adams', 'year': '2001', 'journal-title': 'Cancer Res.'} / Cancer Res. / High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules by Adams (2001)
10.1016/S0169-409X(02)00026-1 / Adv. Drug Deliv. Rev. / PEGylated antibodies and antibody fragments for improved therapy: a review by Chapman (2002)
{'key': '10.1016/j.addr.2008.08.005_bib39', 'series-title': 'The Scientist', 'first-page': '17', 'article-title': 'Therapeutic MAbs: saving lives and making millions', 'author': 'Stacy', 'year': '2005'} / The Scientist / Therapeutic MAbs: saving lives and making millions by Stacy (2005)
10.1016/S1367-5931(00)00216-7 / Curr. Opin. Chem. Biol. / Human antibodies as next generation therapeutics by van Dijk (2001)
10.1006/jmbi.2001.5314 / J. Mol. Biol. / Selection of large diversities of antiidiotypic antibody fragments by phage display by Goletz (2002)
10.1021/bc990076o / Bioconjug. Chem. / Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: a comparison of conjugation chemistries and compounds by Lee (1999)
10.1016/0167-4838(84)90268-1 / Biochim. Biophys. Acta / Physicochemical and biological properties of poly(ethylene glycol)-coupled immunoglobulin G by T (1984)
{'issue': '16', 'key': '10.1016/j.addr.2008.08.005_bib44', 'first-page': '4310', 'article-title': 'Chemical engineering of the monoclonal antibody A7 by polyethylene glycol for targeting cancer chemotherapy', 'volume': '51', 'author': 'Kitamura', 'year': '1991', 'journal-title': 'Cancer Res.'} / Cancer Res. / Chemical engineering of the monoclonal antibody A7 by polyethylene glycol for targeting cancer chemotherapy by Kitamura (1991)
10.1038/11717 / Nat. Biotechnol. / Therapeutic antibody fragments with prolonged in vivo half-lives by Chapman (1999)
10.1073/pnas.88.13.5572 / Proc. Natl. Acad. Sci. U. S. A. / Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis by Leamon (1991)
10.1016/S0021-9258(19)73992-1 / J. Biol. Chem. / Cytotoxicity of momordin-folate conjugates in cultured human cells by Leamon (1992)
10.1016/S0021-9258(19)74542-6 / J. Biol. Chem. / Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells. Contribution of translocation domain by Leamon (1993)
10.1038/scientificamerican0996-150 / Sci. Am. / Fighting cancer by attacking its blood supply by Folkman (1996)
{'key': '10.1016/j.addr.2008.08.005_bib50', 'series-title': 'Antiangiogenic Cancer Therapy', 'author': 'Baker', 'year': '2007'} / Antiangiogenic Cancer Therapy by Baker (2007)
10.1016/S1471-4906(00)01840-8 / Trends Immunol. / Targeting of vasculature in cancer and other angiogenic diseases by Kumar (2001)
10.1038/nm794 / Nat. Med. / A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth by Niethammer (2002)
{'issue': '17', 'key': '10.1016/j.addr.2008.08.005_bib53', 'first-page': '3852', 'article-title': 'Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system', 'volume': '57', 'author': 'Kremer', 'year': '1997', 'journal-title': 'Cancer Res.'} / Cancer Res. / Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system by Kremer (1997)
10.1038/359845a0 / Nature / Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo by Plate (1992)
10.1038/359843a0 / Nature / Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis by Shweiki (1992)
{'issue': '19', 'key': '10.1016/j.addr.2008.08.005_bib56', 'first-page': '4727', 'article-title': 'Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract', 'volume': '53', 'author': 'Brown', 'year': '1993', 'journal-title': 'Cancer Res.'} / Cancer Res. / Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract by Brown (1993)
10.1073/pnas.95.18.10820 / Proc. Natl. Acad. Sci. U. S. A. / Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor by Jain (1998)
10.1074/jbc.270.19.11322 / J. Biol. Chem. / VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells by Cohen (1995)
10.1182/blood.V89.6.1870 / Blood / Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia by Fiedler (1997)
10.1006/bbrc.1995.2832 / Biochem. Biophys. Res. Commun. / Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF by Liu (1995)
{'issue': '2', 'key': '10.1016/j.addr.2008.08.005_bib61', 'first-page': '203', 'article-title': 'Regulation of angiogenesis via vascular endothelial growth factor receptors', 'volume': '60', 'author': 'Veikkola', 'year': '2000', 'journal-title': 'Cancer Res.'} / Cancer Res. / Regulation of angiogenesis via vascular endothelial growth factor receptors by Veikkola (2000)
10.1158/1535-7163.MCT-05-0161 / Mol. Cancer Ther. / Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature by Backer (2005)
10.1016/j.canlet.2005.01.024 / Cancer Lett. / Using anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancer by Chen (2006)
10.1016/S0360-3016(99)00476-9 / Int. J. Radiat. Oncol. Biol. Phys. / Radiation doses to the cell nucleus in single cells and cells in micrometastases in targeted therapy with (131)I labeled ligands or antibodies by Hartman (2000)
10.1007/s002590100484 / Eur. J. Nucl. Med. / General aspects of the cellular response to low- and high-LET radiation by Pouget (2001)
10.1016/j.ijrobp.2003.10.057 / Int. J. Radiat. Oncol. Biol. Phys. / A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles by Li (2004)
10.1023/B:AGEN.0000011801.98187.f2 / Angiogenesis / alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro by Nisato (2003)
10.1126/science.1070200 / Science / Tumor regression by targeted gene delivery to the neovasculature by Hood (2002)
10.1002/anie.200460800 / Angew. Chem., Int. Ed. Engl. / cRGD-functionalized polymer micelles for targeted doxorubicin delivery by Nasongkla (2004)
10.1038/nrc724 / Nat. Rev., Cancer / Specialization of tumour vasculature by Ruoslahti (2002)
10.1016/S0065-230X(08)60772-1 / Adv. Cancer Res. / Fibronectin and its integrin receptors in cancer by Ruoslahti (1999)
10.1016/0092-8674(89)90775-7 / Cell / Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes by Osborn (1989)
10.1093/jnci/dji130 / J. Natl. Cancer Inst. / Specific occlusion of murine and human tumor vasculature by VCAM-1-targeted recombinant fusion proteins by Dienst (2005)
10.1016/j.bbamem.2007.12.021 / Biochim. Biophys. Acta / VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo by Gosk (2008)
10.2174/1568009053765799 / Curr. Cancer Drug Targets / Matrix metalloproteinases as therapeutic targets in cancer by Vihinen (2005)
10.1002/ijc.11526 / Int. J. Cancer / Anti-neovascular therapy by liposomal drug targeted to membrane type-1 matrix metalloproteinase by Kondo (2004)
10.1007/s10555-006-7891-z / Cancer Metastasis Rev. / MT1-MMP: universal or particular player in angiogenesis? by Genis (2006)
10.1073/pnas.241293698 / Proc. Natl. Acad. Sci. U. S. A. / Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis by Jiang (2001)
10.1111/j.1349-7006.2005.00039.x / Cancer Sci. / Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis by Sato (2005)
10.1023/A:1015527220537 / Clin. Exp. Metastasis / MT-MMPs play pivotal roles in cancer dissemination by Yana (2002)
10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B / Int. J. Cancer / Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase by Deryugina (2000)
10.1097/01.cji.0000199196.97845.c3 / J. Immunother. / A review of antibody therapeutics and antibody-related technologies for oncology by Scallon (2006)
10.1016/j.ctrv.2003.10.002 / Cancer Treat. Rev. / Epidermal growth factor receptor: a promising target in solid tumours by Laskin (2004)
10.1016/j.ijpharm.2007.09.024 / Int. J. Pharm. / Ligand based dendritic systems for tumor targeting by Agarwal (2008)
{'issue': '1', 'key': '10.1016/j.addr.2008.08.005_bib85', 'first-page': '19', 'article-title': 'Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells', 'volume': '1', 'author': 'Radinsky', 'year': '1995', 'journal-title': 'Clin. Cancer Res.'} / Clin. Cancer Res. / Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells by Radinsky (1995)
10.1016/S0014-5793(98)00224-5 / FEBS Lett. / Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts by Verbeek (1998)
10.1055/s-2004-829641 / Semin. Respir. Crit. Care Med. / Epidermal growth factor receptor inhibitors in lung cancer therapy by Laskin (2004)
10.1016/S0959-8049(01)00231-3 / Eur. J. Cancer / EGFR and cancer prognosis by Nicholson (2001)
10.1002/ijc.2910620206 / Int. J. Cancer / EGFR gene amplification–rearrangement in human glioblastomas by Schwechheimer (1995)
10.1093/jnci/95.12.851 / J. Natl. Cancer Inst. / Developing inhibitors of the epidermal growth factor receptor for cancer treatment by Grunwald (2003)
10.1200/JCO.2003.01.504 / J. Clin. Oncol. / Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer by Mendelsohn (2003)
10.1021/bc060174r / Bioconjug. Chem. / Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR by Pan (2007)
10.1677/erc.0.0090075 / Endocr. Relat. Cancer / The development and clinical use of trastuzumab (Herceptin) by Harries (2002)
10.1021/bc050137k / Bioconjug. Chem. / Biodegradable nanoparticles for direct or two-step tumor immunotargeting by Nobs (2006)
10.2174/138161280506230110111312 / Curr. Pharm. Des. / Transferrin As A targeting ligand for liposomes and anticancer drugs by Singh (1999)
10.1136/jcp.36.5.539 / J. Clin. Pathol. / Transferrin receptors in human tissues: their distribution and possible clinical relevance by Gatter (1983)
{'issue': '1', 'key': '10.1016/j.addr.2008.08.005_bib97', 'first-page': '57', 'article-title': 'Preliminary clinical study of transferrin-adriamycin conjugate for drug delivery to acute leukemia patients', 'volume': '2', 'author': 'Faulk', 'year': '1990', 'journal-title': 'Mol. Biother.'} / Mol. Biother. / Preliminary clinical study of transferrin-adriamycin conjugate for drug delivery to acute leukemia patients by Faulk (1990)
10.1016/S0065-2571(96)00010-6 / Adv. Enzyme Regul. / Antineoplastic drugs that interfere with iron metabolism in cancer cells by Head (1997)
{'issue': '5', 'key': '10.1016/j.addr.2008.08.005_bib99', 'first-page': '483', 'article-title': 'Technology evaluation: TransMID, KS Biomedix/Nycomed/Sosei/PharmaEngine', 'volume': '7', 'author': 'Rainov', 'year': '2005', 'journal-title': 'Curr. Opin. Mol. Ther.'} / Curr. Opin. Mol. Ther. / Technology evaluation: TransMID, KS Biomedix/Nycomed/Sosei/PharmaEngine by Rainov (2005)
10.1158/0008-5472.CAN-05-0565 / Cancer Res. / Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma by Hu-Lieskovan (2005)
10.1073/pnas.0701458104 / Proc. Natl. Acad. Sci. U. S. A. / Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA by Heidel (2007)
10.4161/cbt.3.7.918 / Cancer Biol. Ther. / Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles by Pun (2004)
{'issue': '3', 'key': '10.1016/j.addr.2008.08.005_bib103', 'first-page': '350', 'article-title': 'Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil', 'volume': '10', 'author': 'Wu', 'year': '2007', 'journal-title': 'J. Pharm. Sci.'} / J. Pharm. Sci. / Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil by Wu (2007)
10.1016/0005-2736(94)00235-H / Biochim. Biophys. Acta / Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro by Lee (1995)
10.1182/blood.V100.2.594 / Blood / Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid by Pan (2002)
10.1016/S0169-409X(99)00062-9 / Adv. Drug Deliv. Rev. / Targeted drug delivery via the folate receptor by Sudimack (2000)
10.1016/j.addr.2004.01.005 / Adv. Drug Deliv. Rev. / Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor by Zhao (2004)
10.1242/jcs.106.1.423 / J. Cell Sci. / Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells by Turek (1993)
10.1016/j.addr.2004.02.003 / Adv. Drug Deliv. Rev. / Folate receptor-targeted drugs for cancer and inflammatory diseases by Low (2004)
10.1016/j.addr.2004.01.001 / Adv. Drug Deliv. Rev. / Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy by Elnakat (2004)
10.1158/1535-7163.MCT-05-0543 / Mol. Cancer Ther. / Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors by Shmeeda (2006)
10.1517/14712598.3.4.563 / Expert Opin. Biol. Ther. / Receptor induction and targeted drug delivery: a new antileukaemia strategy by Ratnam (2003)
10.1016/j.ijpharm.2006.02.027 / Int. J. Pharm. / A folate receptor-targeted liposomal formulation for paclitaxel by Wu (2006)
{'key': '10.1016/j.addr.2008.08.005_bib114', 'series-title': 'Cancer Facts & Figures 2008', 'author': 'Society', 'year': '2008'} / Cancer Facts & Figures 2008 by Society (2008)
10.1016/j.jconrel.2008.03.010 / J. Control. Release / Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy by Chen (2008)
10.1016/j.biomaterials.2006.05.016 / Biomaterials / Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells by Steinhauser (2006)
10.1016/j.biomaterials.2006.11.018 / Biomaterials / Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference by Tan (2007)
10.1016/j.jcis.2004.09.042 / J. Colloid Interface Sci. / Surface modification of monodisperse magnetite nanoparticles for improved intracellular uptake to breast cancer cells by Zhang (2005)
10.1016/j.biomaterials.2008.02.020 / Biomaterials / Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles by Pan (2008)
10.1007/s10549-006-9199-7 / Breast Cancer Res. Treat. / LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases by Leuschner (2006)
10.1016/S1476-5586(03)80046-5 / Neoplasia / Isolation of a colon tumor specific binding peptide using phage display selection by Kelly (2003)
10.2217/14796694.2.6.705 / Future Oncol. / Opportunities for near-infrared thermal ablation of colorectal metastases by guanylyl cyclase C-targeted gold nanoshells by Waldman (2006)
10.1016/j.tibtech.2007.02.005 / Trends Biotech. / Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer by Fortina (2007)
10.1158/0008-5472.CAN-06-1605 / Cancer Res. / Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors by Koizumi (2006)
10.1002/ijc.23381 / Int. J. Cancer / Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil by Nakajima (2008)
10.1038/sj.bjc.6602479 / Br. J. Cancer / NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel by Hamaguchi (2005)
10.1023/A:1026170830782 / Pharm. Res. / Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs by Jelínková (2003)
{'key': '10.1016/j.addr.2008.08.005_bib128', 'series-title': 'Cancer Facts & Figures 2008', 'author': 'Society', 'year': '2008'} / Cancer Facts & Figures 2008 by Society (2008)
10.1016/j.bbrc.2005.05.132 / Biochem. Biophys. Res. Commun. / Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy by Ferrara (2005)
10.1002/cmdc.200800030 / Chem. Med. Chem. / Molecular recognition of small-cell lung cancer cells using aptamers by Chen (2008)
10.1016/j.biomaterials.2007.05.006 / Biomaterials / Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting by Tseng (2007)
10.1021/mp060039w / Mol. Pharmacol. / Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells by Li (2006)
10.1196/annals.1348.001 / Ann. N. Y. Acad. Sci. / Surface-modified LPD nanoparticles for tumor targeting by Li (2006)
{'issue': '1', 'key': '10.1016/j.addr.2008.08.005_bib134', 'first-page': '81', 'article-title': 'Prostate-specific membrane antigen expression in normal and malignant human tissues', 'volume': '3', 'author': 'Silver', 'year': '1997', 'journal-title': 'Clin. Cancer Res.'} / Clin. Cancer Res. / Prostate-specific membrane antigen expression in normal and malignant human tissues by Silver (1997)
10.1002/anie.200602251 / Angew. Chem., Int. Ed. Engl. / An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform by Bagalkot (2006)
10.1016/j.biomaterials.2006.09.047 / Biomaterials / Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery by Cheng (2007)
10.1073/pnas.0601755103 / Proc. Natl. Acad. Sci. U. S. A. / Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo by Farokhzad (2006)
10.1158/0008-5472.CAN-04-2550 / Cancer Res. / Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells by Farokhzad (2004)
10.1517/17425247.3.3.311 / Expert Opin. Drug Deliv. / Nanoparticle-aptamer bioconjugates for cancer targeting by Farokhzad (2006)
{'issue': '9', 'key': '10.1016/j.addr.2008.08.005_bib140', 'first-page': '1445', 'article-title': 'Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells', 'volume': '2', 'author': 'Pinto', 'year': '1996', 'journal-title': 'Clin. Cancer Res.'} / Clin. Cancer Res. / Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells by Pinto (1996)
10.1016/j.jconrel.2004.03.007 / J. Control. Release / Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer by Hattori (2004)
10.1038/sj.cgt.7700844 / Cancer Gene Ther. / Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase by Hattori (2005)
10.1002/ijc.20452 / Int. J. Cancer / Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells by Banerjee (2004)

Dates

Type	When
Created	16 years, 11 months ago (Sept. 21, 2008, 9:21 a.m.)
Deposited	2 years, 3 months ago (May 19, 2023, 9:24 p.m.)
Indexed	5 hours, 42 minutes ago (Aug. 26, 2025, 2:26 a.m.)
Issued	16 years, 8 months ago (Dec. 1, 2008)
Published	16 years, 8 months ago (Dec. 1, 2008)
Published Print	16 years, 8 months ago (Dec. 1, 2008)

Funders 0

None

BibTeX

@article{Byrne_2008, title={Active targeting schemes for nanoparticle systems in cancer therapeutics}, volume={60}, ISSN={0169-409X}, url={http://dx.doi.org/10.1016/j.addr.2008.08.005}, DOI={10.1016/j.addr.2008.08.005}, number={15}, journal={Advanced Drug Delivery Reviews}, publisher={Elsevier BV}, author={Byrne, James D. and Betancourt, Tania and Brannon-Peppas, Lisa}, year={2008}, month=dec, pages={1615–1626} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        26
      ]
    ],
    "date-time": "2025-08-26T06:26:35Z",
    "timestamp": 1756189595186
  },
  "reference-count": 143,
  "publisher": "Elsevier BV",
  "issue": "15",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2008,
            12,
            1
          ]
        ],
        "date-time": "2008-12-01T00:00:00Z",
        "timestamp": 1228089600000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2008,
        12
      ]
    ]
  },
  "DOI": "10.1016/j.addr.2008.08.005",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2008,
        9,
        21
      ]
    ],
    "date-time": "2008-09-21T13:21:54Z",
    "timestamp": 1222003314000
  },
  "page": "1615-1626",
  "source": "Crossref",
  "is-referenced-by-count": 1447,
  "title": "Active targeting schemes for nanoparticle systems in cancer therapeutics",
  "prefix": "10.1016",
  "volume": "60",
  "author": [
    {
      "given": "James D.",
      "family": "Byrne",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Tania",
      "family": "Betancourt",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Lisa",
      "family": "Brannon-Peppas",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "issue": "11",
      "key": "10.1016/j.addr.2008.08.005_bib1",
      "doi-asserted-by": "crossref",
      "first-page": "1649",
      "DOI": "10.1016/j.addr.2004.02.014",
      "article-title": "Nanoparticle and targeted systems for cancer therapy",
      "volume": "56",
      "author": "Brannon-Peppas",
      "year": "2004",
      "journal-title": "Adv. Drug Deliv. Rev."
    },
    {
      "issue": "1",
      "key": "10.1016/j.addr.2008.08.005_bib2",
      "doi-asserted-by": "crossref",
      "first-page": "57",
      "DOI": "10.1016/j.urolonc.2007.03.015",
      "article-title": "Nanoparticles for drug delivery in cancer treatment",
      "volume": "26",
      "author": "Haley",
      "year": "2008",
      "journal-title": "Urol. Oncol."
    },
    {
      "issue": "12",
      "key": "10.1016/j.addr.2008.08.005_bib3",
      "doi-asserted-by": "crossref",
      "first-page": "5317",
      "DOI": "10.1158/0008-5472.CAN-04-3921",
      "article-title": "Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer",
      "volume": "65",
      "author": "Kukowska-Latallo",
      "year": "2005",
      "journal-title": "Cancer Res."
    },
    {
      "issue": "6",
      "key": "10.1016/j.addr.2008.08.005_bib4",
      "doi-asserted-by": "crossref",
      "first-page": "1122",
      "DOI": "10.1021/bc034125f",
      "article-title": "Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery",
      "volume": "14",
      "author": "Bellocq",
      "year": "2003",
      "journal-title": "Bioconjug. Chem."
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib5",
      "doi-asserted-by": "crossref",
      "first-page": "219",
      "DOI": "10.2217/17435889.2.2.219",
      "article-title": "Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation",
      "volume": "2",
      "author": "Betancourt",
      "year": "2007",
      "journal-title": "Nanomed"
    },
    {
      "issue": "6",
      "key": "10.1016/j.addr.2008.08.005_bib6",
      "doi-asserted-by": "crossref",
      "first-page": "1029",
      "DOI": "10.1007/s11095-006-9223-y",
      "article-title": "Functionalized micellar systems for cancer targeted drug delivery",
      "volume": "24",
      "author": "Sutton",
      "year": "2007",
      "journal-title": "Pharm. Res."
    },
    {
      "issue": "21",
      "key": "10.1016/j.addr.2008.08.005_bib7",
      "doi-asserted-by": "crossref",
      "first-page": "1451",
      "DOI": "10.1016/S1359-6446(05)03575-0",
      "article-title": "PEGylation, successful approach to drug delivery",
      "volume": "10",
      "author": "Veronese",
      "year": "2005",
      "journal-title": "Drug Discov. Today"
    },
    {
      "issue": "3",
      "key": "10.1016/j.addr.2008.08.005_bib8",
      "doi-asserted-by": "crossref",
      "first-page": "214",
      "DOI": "10.1593/neo.05769",
      "article-title": "Nanoparticle imaging of integrins on tumor cells",
      "volume": "8",
      "author": "Montet",
      "year": "2006",
      "journal-title": "Neoplasia"
    },
    {
      "issue": "4",
      "key": "10.1016/j.addr.2008.08.005_bib9",
      "doi-asserted-by": "crossref",
      "first-page": "447",
      "DOI": "10.1039/b413435d",
      "article-title": "Selective attachment and release of a chemotherapeutic agent from the interior of a protein cage architecture",
      "author": "Flenniken",
      "year": "2005",
      "journal-title": "Chem. Commun. (Camb.)"
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib10",
      "doi-asserted-by": "crossref",
      "first-page": "149",
      "DOI": "10.2147/nano.2006.1.2.149",
      "article-title": "Immunonanoshells for targeted photothermal ablation of tumor cells",
      "volume": "1",
      "author": "Lowery",
      "year": "2006",
      "journal-title": "Int. J. Nanomed."
    },
    {
      "issue": "33",
      "key": "10.1016/j.addr.2008.08.005_bib11",
      "doi-asserted-by": "crossref",
      "first-page": "11600",
      "DOI": "10.1073/pnas.0502680102",
      "article-title": "Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction",
      "volume": "102",
      "author": "Kam",
      "year": "2005",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "issue": "1\u20132",
      "key": "10.1016/j.addr.2008.08.005_bib12",
      "doi-asserted-by": "crossref",
      "first-page": "111",
      "DOI": "10.1016/S0378-5173(03)00132-7",
      "article-title": "A PEGylated dendritic nanoparticulate carrier of fluorouracil",
      "volume": "257",
      "author": "Bhadra",
      "year": "2003",
      "journal-title": "Int. J. Pharm."
    },
    {
      "issue": "5",
      "key": "10.1016/j.addr.2008.08.005_bib13",
      "doi-asserted-by": "crossref",
      "first-page": "750",
      "DOI": "10.1023/A:1018924219540",
      "article-title": "Influence of poly(DL-lactide) nanocapsules on the biliary clearance and enterohepatic circulation of indomethacin in the rabbit",
      "volume": "10",
      "author": "Fawaz",
      "year": "1993",
      "journal-title": "Pharm. Res."
    },
    {
      "issue": "3\u20134",
      "key": "10.1016/j.addr.2008.08.005_bib14",
      "doi-asserted-by": "crossref",
      "first-page": "301",
      "DOI": "10.1016/S0927-7765(99)00156-3",
      "article-title": "\u2018Stealth\u2019 corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption",
      "volume": "18",
      "author": "Gref",
      "year": "2000",
      "journal-title": "Colloids Surf., B Biointerfaces"
    },
    {
      "issue": "3",
      "key": "10.1016/j.addr.2008.08.005_bib15",
      "doi-asserted-by": "crossref",
      "first-page": "403",
      "DOI": "10.1016/S0169-409X(02)00226-0",
      "article-title": "PEGylated nanoparticles for biological and pharmaceutical applications",
      "volume": "55",
      "author": "Otsuka",
      "year": "2003",
      "journal-title": "Adv. Drug Deliv. Rev."
    },
    {
      "issue": "5",
      "key": "10.1016/j.addr.2008.08.005_bib16",
      "doi-asserted-by": "crossref",
      "first-page": "761",
      "DOI": "10.1038/sj.clpt.6100400",
      "article-title": "Nanoparticles in medicine: therapeutic applications and developments",
      "volume": "83",
      "author": "Zhang",
      "year": "2008",
      "journal-title": "Clin. Pharmacol. Ther."
    },
    {
      "issue": "4",
      "key": "10.1016/j.addr.2008.08.005_bib17",
      "first-page": "209",
      "article-title": "New developments in angiogenesis: a major mechanism for tumor growth and target for therapy",
      "volume": "4",
      "author": "Jones",
      "year": "1998",
      "journal-title": "Cancer J. Sci. Am."
    },
    {
      "issue": "1",
      "key": "10.1016/j.addr.2008.08.005_bib18",
      "doi-asserted-by": "crossref",
      "first-page": "109",
      "DOI": "10.1016/S0169-409X(98)00003-9",
      "article-title": "Control of tumour vascular permeability",
      "volume": "34",
      "author": "Baban",
      "year": "1998",
      "journal-title": "Adv. Drug Deliv. Rev."
    },
    {
      "issue": "8",
      "key": "10.1016/j.addr.2008.08.005_bib19",
      "doi-asserted-by": "crossref",
      "first-page": "4607",
      "DOI": "10.1073/pnas.95.8.4607",
      "article-title": "Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment",
      "volume": "95",
      "author": "Hobbs",
      "year": "1998",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "issue": "4",
      "key": "10.1016/j.addr.2008.08.005_bib20",
      "doi-asserted-by": "crossref",
      "first-page": "346",
      "DOI": "10.1016/S0009-9260(66)80052-1",
      "article-title": "Microcirculation of tumors. II. The supervascularized state of irradiated regressing tumors",
      "volume": "17",
      "author": "Rubin",
      "year": "1966",
      "journal-title": "Clin. Radiol."
    },
    {
      "issue": "3",
      "key": "10.1016/j.addr.2008.08.005_bib21",
      "doi-asserted-by": "crossref",
      "first-page": "211",
      "DOI": "10.1007/BF00409698",
      "article-title": "Vascularization of tumors: a review",
      "volume": "103",
      "author": "Shubik",
      "year": "1982",
      "journal-title": "J. Cancer Res. Clin. Oncol."
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib22",
      "doi-asserted-by": "crossref",
      "first-page": "275",
      "DOI": "10.1084/jem.133.2.275",
      "article-title": "Isolation of a tumor factor responsible for angiogenesis",
      "volume": "133",
      "author": "Folkman",
      "year": "1971",
      "journal-title": "J. Exp. Med."
    },
    {
      "issue": "4",
      "key": "10.1016/j.addr.2008.08.005_bib23",
      "doi-asserted-by": "crossref",
      "first-page": "561",
      "DOI": "10.1002/ijc.11108",
      "article-title": "Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels",
      "volume": "105",
      "author": "Krasnici",
      "year": "2003",
      "journal-title": "Int. J. Cancer"
    },
    {
      "issue": "3",
      "key": "10.1016/j.addr.2008.08.005_bib24",
      "doi-asserted-by": "crossref",
      "first-page": "476",
      "DOI": "10.1046/j.1523-1747.2003.12057.x",
      "article-title": "Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a \u201chumanized\u201d SCID mouse model",
      "volume": "120",
      "author": "Kunstfeld",
      "year": "2003",
      "journal-title": "J. Invest. Dermatol."
    },
    {
      "issue": "21",
      "key": "10.1016/j.addr.2008.08.005_bib25",
      "first-page": "6132",
      "article-title": "Increased exposure of anionic phospholipids on the surface of tumor blood vessels",
      "volume": "62",
      "author": "Ran",
      "year": "2002",
      "journal-title": "Cancer Res."
    },
    {
      "issue": "7",
      "key": "10.1016/j.addr.2008.08.005_bib26",
      "doi-asserted-by": "crossref",
      "first-page": "1401",
      "DOI": "10.1172/JCI965",
      "article-title": "Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice",
      "volume": "101",
      "author": "Thurston",
      "year": "1998",
      "journal-title": "J. Clin. Invest."
    },
    {
      "issue": "13",
      "key": "10.1016/j.addr.2008.08.005_bib27",
      "doi-asserted-by": "crossref",
      "first-page": "6732",
      "DOI": "10.1158/0008-5472.CAN-05-4199",
      "article-title": "Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models",
      "volume": "66",
      "author": "Kirpotin",
      "year": "2006",
      "journal-title": "Cancer Res."
    },
    {
      "issue": "1\u20132",
      "key": "10.1016/j.addr.2008.08.005_bib28",
      "doi-asserted-by": "crossref",
      "first-page": "194",
      "DOI": "10.1016/j.ijpharm.2007.04.037",
      "article-title": "Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes",
      "volume": "342",
      "author": "Hatakeyama",
      "year": "2007",
      "journal-title": "Int. J. Pharm."
    },
    {
      "key": "10.1016/j.addr.2008.08.005_bib29",
      "doi-asserted-by": "crossref",
      "first-page": "285",
      "DOI": "10.1016/S0083-6729(00)60022-5",
      "article-title": "Liposome targeting to tumors using vitamin and growth factor receptors",
      "volume": "60",
      "author": "Drummond",
      "year": "2000",
      "journal-title": "Vitam. Horm."
    },
    {
      "issue": "1",
      "key": "10.1016/j.addr.2008.08.005_bib30",
      "doi-asserted-by": "crossref",
      "first-page": "130",
      "DOI": "10.1002/ijc.10242",
      "article-title": "Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer",
      "volume": "99",
      "author": "Iinuma",
      "year": "2002",
      "journal-title": "Int. J. Cancer."
    },
    {
      "issue": "1\u20132",
      "key": "10.1016/j.addr.2008.08.005_bib31",
      "doi-asserted-by": "crossref",
      "first-page": "94",
      "DOI": "10.1016/j.ijpharm.2006.08.039",
      "article-title": "Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells",
      "volume": "329",
      "author": "Kobayashi",
      "year": "2007",
      "journal-title": "Int. J. Pharm."
    },
    {
      "issue": "15",
      "key": "10.1016/j.addr.2008.08.005_bib32",
      "first-page": "3320",
      "article-title": "In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma",
      "volume": "58",
      "author": "Lopes de Menezes",
      "year": "1998",
      "journal-title": "Cancer Res."
    },
    {
      "issue": "5",
      "key": "10.1016/j.addr.2008.08.005_bib33",
      "doi-asserted-by": "crossref",
      "first-page": "972",
      "DOI": "10.1248/bpb.30.972",
      "article-title": "In vitro efficacy of a sterically stabilized immunoliposomes targeted to membrane type 1 matrix metalloproteinase (MT1-MMP)",
      "volume": "30",
      "author": "Atobe",
      "year": "2007",
      "journal-title": "Biol. Pharm. Bull."
    },
    {
      "issue": "1",
      "key": "10.1016/j.addr.2008.08.005_bib34",
      "doi-asserted-by": "crossref",
      "first-page": "177",
      "DOI": "10.1016/S0014-5793(97)00905-8",
      "article-title": "Immunoliposomes bearing polyethyleneglycol-coupled Fab\u2032 fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo",
      "volume": "413",
      "author": "Maruyama",
      "year": "1997",
      "journal-title": "FEBS Lett."
    },
    {
      "issue": "1",
      "key": "10.1016/j.addr.2008.08.005_bib35",
      "doi-asserted-by": "crossref",
      "first-page": "50",
      "DOI": "10.1016/j.jconrel.2007.11.005",
      "article-title": "Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab\u2032 fragments and single chain Fv",
      "volume": "126",
      "author": "Cheng",
      "year": "2008",
      "journal-title": "J. Control. Release"
    },
    {
      "issue": "3",
      "key": "10.1016/j.addr.2008.08.005_bib36",
      "doi-asserted-by": "crossref",
      "first-page": "1100",
      "DOI": "10.1158/1078-0432.CCR-03-0041",
      "article-title": "Improved therapeutic responses in a xenograft model of human B lymphoma (Namalwa) for liposomal vincristine versus liposomal doxorubicin targeted via anti-CD19 IgG2a or Fab\u2032 fragments",
      "volume": "10",
      "author": "Sapra",
      "year": "2004",
      "journal-title": "Clin. Cancer Res."
    },
    {
      "issue": "12",
      "key": "10.1016/j.addr.2008.08.005_bib37",
      "first-page": "4750",
      "article-title": "High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules",
      "volume": "61",
      "author": "Adams",
      "year": "2001",
      "journal-title": "Cancer Res."
    },
    {
      "issue": "4",
      "key": "10.1016/j.addr.2008.08.005_bib38",
      "doi-asserted-by": "crossref",
      "first-page": "531",
      "DOI": "10.1016/S0169-409X(02)00026-1",
      "article-title": "PEGylated antibodies and antibody fragments for improved therapy: a review",
      "volume": "54",
      "author": "Chapman",
      "year": "2002",
      "journal-title": "Adv. Drug Deliv. Rev."
    },
    {
      "key": "10.1016/j.addr.2008.08.005_bib39",
      "series-title": "The Scientist",
      "first-page": "17",
      "article-title": "Therapeutic MAbs: saving lives and making millions",
      "author": "Stacy",
      "year": "2005"
    },
    {
      "issue": "4",
      "key": "10.1016/j.addr.2008.08.005_bib40",
      "doi-asserted-by": "crossref",
      "first-page": "368",
      "DOI": "10.1016/S1367-5931(00)00216-7",
      "article-title": "Human antibodies as next generation therapeutics",
      "volume": "5",
      "author": "van Dijk",
      "year": "2001",
      "journal-title": "Curr. Opin. Chem. Biol."
    },
    {
      "issue": "5",
      "key": "10.1016/j.addr.2008.08.005_bib41",
      "doi-asserted-by": "crossref",
      "first-page": "1087",
      "DOI": "10.1006/jmbi.2001.5314",
      "article-title": "Selection of large diversities of antiidiotypic antibody fragments by phage display",
      "volume": "315",
      "author": "Goletz",
      "year": "2002",
      "journal-title": "J. Mol. Biol."
    },
    {
      "issue": "6",
      "key": "10.1016/j.addr.2008.08.005_bib42",
      "doi-asserted-by": "crossref",
      "first-page": "973",
      "DOI": "10.1021/bc990076o",
      "article-title": "Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: a comparison of conjugation chemistries and compounds",
      "volume": "10",
      "author": "Lee",
      "year": "1999",
      "journal-title": "Bioconjug. Chem."
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib43",
      "doi-asserted-by": "crossref",
      "first-page": "248",
      "DOI": "10.1016/0167-4838(84)90268-1",
      "article-title": "Physicochemical and biological properties of poly(ethylene glycol)-coupled immunoglobulin G",
      "volume": "788",
      "author": "T",
      "year": "1984",
      "journal-title": "Biochim. Biophys. Acta"
    },
    {
      "issue": "16",
      "key": "10.1016/j.addr.2008.08.005_bib44",
      "first-page": "4310",
      "article-title": "Chemical engineering of the monoclonal antibody A7 by polyethylene glycol for targeting cancer chemotherapy",
      "volume": "51",
      "author": "Kitamura",
      "year": "1991",
      "journal-title": "Cancer Res."
    },
    {
      "issue": "8",
      "key": "10.1016/j.addr.2008.08.005_bib45",
      "doi-asserted-by": "crossref",
      "first-page": "780",
      "DOI": "10.1038/11717",
      "article-title": "Therapeutic antibody fragments with prolonged in vivo half-lives",
      "volume": "17",
      "author": "Chapman",
      "year": "1999",
      "journal-title": "Nat. Biotechnol."
    },
    {
      "issue": "13",
      "key": "10.1016/j.addr.2008.08.005_bib46",
      "doi-asserted-by": "crossref",
      "first-page": "5572",
      "DOI": "10.1073/pnas.88.13.5572",
      "article-title": "Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis",
      "volume": "88",
      "author": "Leamon",
      "year": "1991",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "issue": "35",
      "key": "10.1016/j.addr.2008.08.005_bib47",
      "doi-asserted-by": "crossref",
      "first-page": "24966",
      "DOI": "10.1016/S0021-9258(19)73992-1",
      "article-title": "Cytotoxicity of momordin-folate conjugates in cultured human cells",
      "volume": "267",
      "author": "Leamon",
      "year": "1992",
      "journal-title": "J. Biol. Chem."
    },
    {
      "issue": "33",
      "key": "10.1016/j.addr.2008.08.005_bib48",
      "doi-asserted-by": "crossref",
      "first-page": "24847",
      "DOI": "10.1016/S0021-9258(19)74542-6",
      "article-title": "Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells. Contribution of translocation domain",
      "volume": "268",
      "author": "Leamon",
      "year": "1993",
      "journal-title": "J. Biol. Chem."
    },
    {
      "issue": "3",
      "key": "10.1016/j.addr.2008.08.005_bib49",
      "doi-asserted-by": "crossref",
      "first-page": "150",
      "DOI": "10.1038/scientificamerican0996-150",
      "article-title": "Fighting cancer by attacking its blood supply",
      "volume": "275",
      "author": "Folkman",
      "year": "1996",
      "journal-title": "Sci. Am."
    },
    {
      "key": "10.1016/j.addr.2008.08.005_bib50",
      "series-title": "Antiangiogenic Cancer Therapy",
      "author": "Baker",
      "year": "2007"
    },
    {
      "issue": "3",
      "key": "10.1016/j.addr.2008.08.005_bib51",
      "doi-asserted-by": "crossref",
      "first-page": "129",
      "DOI": "10.1016/S1471-4906(00)01840-8",
      "article-title": "Targeting of vasculature in cancer and other angiogenic diseases",
      "volume": "22",
      "author": "Kumar",
      "year": "2001",
      "journal-title": "Trends Immunol."
    },
    {
      "issue": "12",
      "key": "10.1016/j.addr.2008.08.005_bib52",
      "doi-asserted-by": "crossref",
      "first-page": "1369",
      "DOI": "10.1038/nm794",
      "article-title": "A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth",
      "volume": "8",
      "author": "Niethammer",
      "year": "2002",
      "journal-title": "Nat. Med."
    },
    {
      "issue": "17",
      "key": "10.1016/j.addr.2008.08.005_bib53",
      "first-page": "3852",
      "article-title": "Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system",
      "volume": "57",
      "author": "Kremer",
      "year": "1997",
      "journal-title": "Cancer Res."
    },
    {
      "issue": "6398",
      "key": "10.1016/j.addr.2008.08.005_bib54",
      "doi-asserted-by": "crossref",
      "first-page": "845",
      "DOI": "10.1038/359845a0",
      "article-title": "Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo",
      "volume": "359",
      "author": "Plate",
      "year": "1992",
      "journal-title": "Nature"
    },
    {
      "issue": "6398",
      "key": "10.1016/j.addr.2008.08.005_bib55",
      "doi-asserted-by": "crossref",
      "first-page": "843",
      "DOI": "10.1038/359843a0",
      "article-title": "Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis",
      "volume": "359",
      "author": "Shweiki",
      "year": "1992",
      "journal-title": "Nature"
    },
    {
      "issue": "19",
      "key": "10.1016/j.addr.2008.08.005_bib56",
      "first-page": "4727",
      "article-title": "Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract",
      "volume": "53",
      "author": "Brown",
      "year": "1993",
      "journal-title": "Cancer Res."
    },
    {
      "issue": "18",
      "key": "10.1016/j.addr.2008.08.005_bib57",
      "doi-asserted-by": "crossref",
      "first-page": "10820",
      "DOI": "10.1073/pnas.95.18.10820",
      "article-title": "Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor",
      "volume": "95",
      "author": "Jain",
      "year": "1998",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "issue": "19",
      "key": "10.1016/j.addr.2008.08.005_bib58",
      "doi-asserted-by": "crossref",
      "first-page": "11322",
      "DOI": "10.1074/jbc.270.19.11322",
      "article-title": "VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells",
      "volume": "270",
      "author": "Cohen",
      "year": "1995",
      "journal-title": "J. Biol. Chem."
    },
    {
      "issue": "6",
      "key": "10.1016/j.addr.2008.08.005_bib59",
      "doi-asserted-by": "crossref",
      "first-page": "1870",
      "DOI": "10.1182/blood.V89.6.1870",
      "article-title": "Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia",
      "volume": "89",
      "author": "Fiedler",
      "year": "1997",
      "journal-title": "Blood"
    },
    {
      "issue": "3",
      "key": "10.1016/j.addr.2008.08.005_bib60",
      "doi-asserted-by": "crossref",
      "first-page": "721",
      "DOI": "10.1006/bbrc.1995.2832",
      "article-title": "Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF",
      "volume": "217",
      "author": "Liu",
      "year": "1995",
      "journal-title": "Biochem. Biophys. Res. Commun."
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib61",
      "first-page": "203",
      "article-title": "Regulation of angiogenesis via vascular endothelial growth factor receptors",
      "volume": "60",
      "author": "Veikkola",
      "year": "2000",
      "journal-title": "Cancer Res."
    },
    {
      "issue": "9",
      "key": "10.1016/j.addr.2008.08.005_bib62",
      "doi-asserted-by": "crossref",
      "first-page": "1423",
      "DOI": "10.1158/1535-7163.MCT-05-0161",
      "article-title": "Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature",
      "volume": "4",
      "author": "Backer",
      "year": "2005",
      "journal-title": "Mol. Cancer Ther."
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib63",
      "doi-asserted-by": "crossref",
      "first-page": "169",
      "DOI": "10.1016/j.canlet.2005.01.024",
      "article-title": "Using anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancer",
      "volume": "231",
      "author": "Chen",
      "year": "2006",
      "journal-title": "Cancer Lett."
    },
    {
      "issue": "4",
      "key": "10.1016/j.addr.2008.08.005_bib64",
      "doi-asserted-by": "crossref",
      "first-page": "1025",
      "DOI": "10.1016/S0360-3016(99)00476-9",
      "article-title": "Radiation doses to the cell nucleus in single cells and cells in micrometastases in targeted therapy with (131)I labeled ligands or antibodies",
      "volume": "46",
      "author": "Hartman",
      "year": "2000",
      "journal-title": "Int. J. Radiat. Oncol. Biol. Phys."
    },
    {
      "issue": "4",
      "key": "10.1016/j.addr.2008.08.005_bib65",
      "doi-asserted-by": "crossref",
      "first-page": "541",
      "DOI": "10.1007/s002590100484",
      "article-title": "General aspects of the cellular response to low- and high-LET radiation",
      "volume": "28",
      "author": "Pouget",
      "year": "2001",
      "journal-title": "Eur. J. Nucl. Med."
    },
    {
      "issue": "4",
      "key": "10.1016/j.addr.2008.08.005_bib66",
      "doi-asserted-by": "crossref",
      "first-page": "1215",
      "DOI": "10.1016/j.ijrobp.2003.10.057",
      "article-title": "A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles",
      "volume": "58",
      "author": "Li",
      "year": "2004",
      "journal-title": "Int. J. Radiat. Oncol. Biol. Phys."
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib67",
      "doi-asserted-by": "crossref",
      "first-page": "105",
      "DOI": "10.1023/B:AGEN.0000011801.98187.f2",
      "article-title": "alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro",
      "volume": "6",
      "author": "Nisato",
      "year": "2003",
      "journal-title": "Angiogenesis"
    },
    {
      "issue": "5577",
      "key": "10.1016/j.addr.2008.08.005_bib68",
      "doi-asserted-by": "crossref",
      "first-page": "2404",
      "DOI": "10.1126/science.1070200",
      "article-title": "Tumor regression by targeted gene delivery to the neovasculature",
      "volume": "296",
      "author": "Hood",
      "year": "2002",
      "journal-title": "Science"
    },
    {
      "issue": "46",
      "key": "10.1016/j.addr.2008.08.005_bib69",
      "doi-asserted-by": "crossref",
      "first-page": "6323",
      "DOI": "10.1002/anie.200460800",
      "article-title": "cRGD-functionalized polymer micelles for targeted doxorubicin delivery",
      "volume": "43",
      "author": "Nasongkla",
      "year": "2004",
      "journal-title": "Angew. Chem., Int. Ed. Engl."
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib70",
      "doi-asserted-by": "crossref",
      "first-page": "83",
      "DOI": "10.1038/nrc724",
      "article-title": "Specialization of tumour vasculature",
      "volume": "2",
      "author": "Ruoslahti",
      "year": "2002",
      "journal-title": "Nat. Rev., Cancer"
    },
    {
      "key": "10.1016/j.addr.2008.08.005_bib71",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1016/S0065-230X(08)60772-1",
      "article-title": "Fibronectin and its integrin receptors in cancer",
      "volume": "76",
      "author": "Ruoslahti",
      "year": "1999",
      "journal-title": "Adv. Cancer Res."
    },
    {
      "issue": "6",
      "key": "10.1016/j.addr.2008.08.005_bib72",
      "doi-asserted-by": "crossref",
      "first-page": "1203",
      "DOI": "10.1016/0092-8674(89)90775-7",
      "article-title": "Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes",
      "volume": "59",
      "author": "Osborn",
      "year": "1989",
      "journal-title": "Cell"
    },
    {
      "issue": "10",
      "key": "10.1016/j.addr.2008.08.005_bib73",
      "doi-asserted-by": "crossref",
      "first-page": "733",
      "DOI": "10.1093/jnci/dji130",
      "article-title": "Specific occlusion of murine and human tumor vasculature by VCAM-1-targeted recombinant fusion proteins",
      "volume": "97",
      "author": "Dienst",
      "year": "2005",
      "journal-title": "J. Natl. Cancer Inst."
    },
    {
      "issue": "4",
      "key": "10.1016/j.addr.2008.08.005_bib74",
      "doi-asserted-by": "crossref",
      "first-page": "854",
      "DOI": "10.1016/j.bbamem.2007.12.021",
      "article-title": "VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo",
      "volume": "1778",
      "author": "Gosk",
      "year": "2008",
      "journal-title": "Biochim. Biophys. Acta"
    },
    {
      "issue": "3",
      "key": "10.1016/j.addr.2008.08.005_bib75",
      "doi-asserted-by": "crossref",
      "first-page": "203",
      "DOI": "10.2174/1568009053765799",
      "article-title": "Matrix metalloproteinases as therapeutic targets in cancer",
      "volume": "5",
      "author": "Vihinen",
      "year": "2005",
      "journal-title": "Curr. Cancer Drug Targets"
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib76",
      "doi-asserted-by": "crossref",
      "first-page": "301",
      "DOI": "10.1002/ijc.11526",
      "article-title": "Anti-neovascular therapy by liposomal drug targeted to membrane type-1 matrix metalloproteinase",
      "volume": "108",
      "author": "Kondo",
      "year": "2004",
      "journal-title": "Int. J. Cancer"
    },
    {
      "issue": "1",
      "key": "10.1016/j.addr.2008.08.005_bib77",
      "doi-asserted-by": "crossref",
      "first-page": "77",
      "DOI": "10.1007/s10555-006-7891-z",
      "article-title": "MT1-MMP: universal or particular player in angiogenesis?",
      "volume": "25",
      "author": "Genis",
      "year": "2006",
      "journal-title": "Cancer Metastasis Rev."
    },
    {
      "issue": "24",
      "key": "10.1016/j.addr.2008.08.005_bib78",
      "doi-asserted-by": "crossref",
      "first-page": "13693",
      "DOI": "10.1073/pnas.241293698",
      "article-title": "Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis",
      "volume": "98",
      "author": "Jiang",
      "year": "2001",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "issue": "4",
      "key": "10.1016/j.addr.2008.08.005_bib79",
      "doi-asserted-by": "crossref",
      "first-page": "212",
      "DOI": "10.1111/j.1349-7006.2005.00039.x",
      "article-title": "Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis",
      "volume": "96",
      "author": "Sato",
      "year": "2005",
      "journal-title": "Cancer Sci."
    },
    {
      "issue": "3",
      "key": "10.1016/j.addr.2008.08.005_bib80",
      "doi-asserted-by": "crossref",
      "first-page": "209",
      "DOI": "10.1023/A:1015527220537",
      "article-title": "MT-MMPs play pivotal roles in cancer dissemination",
      "volume": "19",
      "author": "Yana",
      "year": "2002",
      "journal-title": "Clin. Exp. Metastasis"
    },
    {
      "issue": "1",
      "key": "10.1016/j.addr.2008.08.005_bib81",
      "doi-asserted-by": "crossref",
      "first-page": "15",
      "DOI": "10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B",
      "article-title": "Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase",
      "volume": "86",
      "author": "Deryugina",
      "year": "2000",
      "journal-title": "Int. J. Cancer"
    },
    {
      "issue": "4",
      "key": "10.1016/j.addr.2008.08.005_bib82",
      "doi-asserted-by": "crossref",
      "first-page": "351",
      "DOI": "10.1097/01.cji.0000199196.97845.c3",
      "article-title": "A review of antibody therapeutics and antibody-related technologies for oncology",
      "volume": "29",
      "author": "Scallon",
      "year": "2006",
      "journal-title": "J. Immunother."
    },
    {
      "issue": "1",
      "key": "10.1016/j.addr.2008.08.005_bib83",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1016/j.ctrv.2003.10.002",
      "article-title": "Epidermal growth factor receptor: a promising target in solid tumours",
      "volume": "30",
      "author": "Laskin",
      "year": "2004",
      "journal-title": "Cancer Treat. Rev."
    },
    {
      "issue": "1\u20132",
      "key": "10.1016/j.addr.2008.08.005_bib84",
      "doi-asserted-by": "crossref",
      "first-page": "3",
      "DOI": "10.1016/j.ijpharm.2007.09.024",
      "article-title": "Ligand based dendritic systems for tumor targeting",
      "volume": "350",
      "author": "Agarwal",
      "year": "2008",
      "journal-title": "Int. J. Pharm."
    },
    {
      "issue": "1",
      "key": "10.1016/j.addr.2008.08.005_bib85",
      "first-page": "19",
      "article-title": "Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells",
      "volume": "1",
      "author": "Radinsky",
      "year": "1995",
      "journal-title": "Clin. Cancer Res."
    },
    {
      "issue": "1",
      "key": "10.1016/j.addr.2008.08.005_bib86",
      "doi-asserted-by": "crossref",
      "first-page": "145",
      "DOI": "10.1016/S0014-5793(98)00224-5",
      "article-title": "Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts",
      "volume": "425",
      "author": "Verbeek",
      "year": "1998",
      "journal-title": "FEBS Lett."
    },
    {
      "issue": "Suppl 1",
      "key": "10.1016/j.addr.2008.08.005_bib87",
      "doi-asserted-by": "crossref",
      "first-page": "17",
      "DOI": "10.1055/s-2004-829641",
      "article-title": "Epidermal growth factor receptor inhibitors in lung cancer therapy",
      "volume": "25",
      "author": "Laskin",
      "year": "2004",
      "journal-title": "Semin. Respir. Crit. Care Med."
    },
    {
      "issue": "Suppl 4",
      "key": "10.1016/j.addr.2008.08.005_bib88",
      "doi-asserted-by": "crossref",
      "first-page": "S9",
      "DOI": "10.1016/S0959-8049(01)00231-3",
      "article-title": "EGFR and cancer prognosis",
      "volume": "37",
      "author": "Nicholson",
      "year": "2001",
      "journal-title": "Eur. J. Cancer"
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib89",
      "doi-asserted-by": "crossref",
      "first-page": "145",
      "DOI": "10.1002/ijc.2910620206",
      "article-title": "EGFR gene amplification\u2013rearrangement in human glioblastomas",
      "volume": "62",
      "author": "Schwechheimer",
      "year": "1995",
      "journal-title": "Int. J. Cancer"
    },
    {
      "issue": "12",
      "key": "10.1016/j.addr.2008.08.005_bib90",
      "doi-asserted-by": "crossref",
      "first-page": "851",
      "DOI": "10.1093/jnci/95.12.851",
      "article-title": "Developing inhibitors of the epidermal growth factor receptor for cancer treatment",
      "volume": "95",
      "author": "Grunwald",
      "year": "2003",
      "journal-title": "J. Natl. Cancer Inst."
    },
    {
      "issue": "14",
      "key": "10.1016/j.addr.2008.08.005_bib91",
      "doi-asserted-by": "crossref",
      "first-page": "2787",
      "DOI": "10.1200/JCO.2003.01.504",
      "article-title": "Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer",
      "volume": "21",
      "author": "Mendelsohn",
      "year": "2003",
      "journal-title": "J. Clin. Oncol."
    },
    {
      "issue": "1",
      "key": "10.1016/j.addr.2008.08.005_bib92",
      "doi-asserted-by": "crossref",
      "first-page": "101",
      "DOI": "10.1021/bc060174r",
      "article-title": "Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR",
      "volume": "18",
      "author": "Pan",
      "year": "2007",
      "journal-title": "Bioconjug. Chem."
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib93",
      "doi-asserted-by": "crossref",
      "first-page": "75",
      "DOI": "10.1677/erc.0.0090075",
      "article-title": "The development and clinical use of trastuzumab (Herceptin)",
      "volume": "9",
      "author": "Harries",
      "year": "2002",
      "journal-title": "Endocr. Relat. Cancer"
    },
    {
      "issue": "1",
      "key": "10.1016/j.addr.2008.08.005_bib94",
      "doi-asserted-by": "crossref",
      "first-page": "139",
      "DOI": "10.1021/bc050137k",
      "article-title": "Biodegradable nanoparticles for direct or two-step tumor immunotargeting",
      "volume": "17",
      "author": "Nobs",
      "year": "2006",
      "journal-title": "Bioconjug. Chem."
    },
    {
      "issue": "6",
      "key": "10.1016/j.addr.2008.08.005_bib95",
      "doi-asserted-by": "crossref",
      "first-page": "443",
      "DOI": "10.2174/138161280506230110111312",
      "article-title": "Transferrin As A targeting ligand for liposomes and anticancer drugs",
      "volume": "5",
      "author": "Singh",
      "year": "1999",
      "journal-title": "Curr. Pharm. Des."
    },
    {
      "issue": "5",
      "key": "10.1016/j.addr.2008.08.005_bib96",
      "doi-asserted-by": "crossref",
      "first-page": "539",
      "DOI": "10.1136/jcp.36.5.539",
      "article-title": "Transferrin receptors in human tissues: their distribution and possible clinical relevance",
      "volume": "36",
      "author": "Gatter",
      "year": "1983",
      "journal-title": "J. Clin. Pathol."
    },
    {
      "issue": "1",
      "key": "10.1016/j.addr.2008.08.005_bib97",
      "first-page": "57",
      "article-title": "Preliminary clinical study of transferrin-adriamycin conjugate for drug delivery to acute leukemia patients",
      "volume": "2",
      "author": "Faulk",
      "year": "1990",
      "journal-title": "Mol. Biother."
    },
    {
      "key": "10.1016/j.addr.2008.08.005_bib98",
      "doi-asserted-by": "crossref",
      "first-page": "147",
      "DOI": "10.1016/S0065-2571(96)00010-6",
      "article-title": "Antineoplastic drugs that interfere with iron metabolism in cancer cells",
      "volume": "37",
      "author": "Head",
      "year": "1997",
      "journal-title": "Adv. Enzyme Regul."
    },
    {
      "issue": "5",
      "key": "10.1016/j.addr.2008.08.005_bib99",
      "first-page": "483",
      "article-title": "Technology evaluation: TransMID, KS Biomedix/Nycomed/Sosei/PharmaEngine",
      "volume": "7",
      "author": "Rainov",
      "year": "2005",
      "journal-title": "Curr. Opin. Mol. Ther."
    },
    {
      "issue": "19",
      "key": "10.1016/j.addr.2008.08.005_bib100",
      "doi-asserted-by": "crossref",
      "first-page": "8984",
      "DOI": "10.1158/0008-5472.CAN-05-0565",
      "article-title": "Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma",
      "volume": "65",
      "author": "Hu-Lieskovan",
      "year": "2005",
      "journal-title": "Cancer Res."
    },
    {
      "issue": "14",
      "key": "10.1016/j.addr.2008.08.005_bib101",
      "doi-asserted-by": "crossref",
      "first-page": "5715",
      "DOI": "10.1073/pnas.0701458104",
      "article-title": "Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA",
      "volume": "104",
      "author": "Heidel",
      "year": "2007",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "issue": "7",
      "key": "10.1016/j.addr.2008.08.005_bib102",
      "doi-asserted-by": "crossref",
      "first-page": "641",
      "DOI": "10.4161/cbt.3.7.918",
      "article-title": "Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles",
      "volume": "3",
      "author": "Pun",
      "year": "2004",
      "journal-title": "Cancer Biol. Ther."
    },
    {
      "issue": "3",
      "key": "10.1016/j.addr.2008.08.005_bib103",
      "first-page": "350",
      "article-title": "Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil",
      "volume": "10",
      "author": "Wu",
      "year": "2007",
      "journal-title": "J. Pharm. Sci."
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib104",
      "doi-asserted-by": "crossref",
      "first-page": "134",
      "DOI": "10.1016/0005-2736(94)00235-H",
      "article-title": "Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro",
      "volume": "1233",
      "author": "Lee",
      "year": "1995",
      "journal-title": "Biochim. Biophys. Acta"
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib105",
      "doi-asserted-by": "crossref",
      "first-page": "594",
      "DOI": "10.1182/blood.V100.2.594",
      "article-title": "Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid",
      "volume": "100",
      "author": "Pan",
      "year": "2002",
      "journal-title": "Blood"
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib106",
      "doi-asserted-by": "crossref",
      "first-page": "147",
      "DOI": "10.1016/S0169-409X(99)00062-9",
      "article-title": "Targeted drug delivery via the folate receptor",
      "volume": "41",
      "author": "Sudimack",
      "year": "2000",
      "journal-title": "Adv. Drug Deliv. Rev."
    },
    {
      "issue": "8",
      "key": "10.1016/j.addr.2008.08.005_bib107",
      "doi-asserted-by": "crossref",
      "first-page": "1193",
      "DOI": "10.1016/j.addr.2004.01.005",
      "article-title": "Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor",
      "volume": "56",
      "author": "Zhao",
      "year": "2004",
      "journal-title": "Adv. Drug Deliv. Rev."
    },
    {
      "issue": "Pt 1",
      "key": "10.1016/j.addr.2008.08.005_bib108",
      "doi-asserted-by": "crossref",
      "first-page": "423",
      "DOI": "10.1242/jcs.106.1.423",
      "article-title": "Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells",
      "volume": "106",
      "author": "Turek",
      "year": "1993",
      "journal-title": "J. Cell Sci."
    },
    {
      "issue": "8",
      "key": "10.1016/j.addr.2008.08.005_bib109",
      "doi-asserted-by": "crossref",
      "first-page": "1055",
      "DOI": "10.1016/j.addr.2004.02.003",
      "article-title": "Folate receptor-targeted drugs for cancer and inflammatory diseases",
      "volume": "56",
      "author": "Low",
      "year": "2004",
      "journal-title": "Adv. Drug Deliv. Rev."
    },
    {
      "issue": "8",
      "key": "10.1016/j.addr.2008.08.005_bib110",
      "doi-asserted-by": "crossref",
      "first-page": "1067",
      "DOI": "10.1016/j.addr.2004.01.001",
      "article-title": "Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy",
      "volume": "56",
      "author": "Elnakat",
      "year": "2004",
      "journal-title": "Adv. Drug Deliv. Rev."
    },
    {
      "issue": "4",
      "key": "10.1016/j.addr.2008.08.005_bib111",
      "doi-asserted-by": "crossref",
      "first-page": "818",
      "DOI": "10.1158/1535-7163.MCT-05-0543",
      "article-title": "Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors",
      "volume": "5",
      "author": "Shmeeda",
      "year": "2006",
      "journal-title": "Mol. Cancer Ther."
    },
    {
      "issue": "4",
      "key": "10.1016/j.addr.2008.08.005_bib112",
      "doi-asserted-by": "crossref",
      "first-page": "563",
      "DOI": "10.1517/14712598.3.4.563",
      "article-title": "Receptor induction and targeted drug delivery: a new antileukaemia strategy",
      "volume": "3",
      "author": "Ratnam",
      "year": "2003",
      "journal-title": "Expert Opin. Biol. Ther."
    },
    {
      "issue": "1\u20132",
      "key": "10.1016/j.addr.2008.08.005_bib113",
      "doi-asserted-by": "crossref",
      "first-page": "148",
      "DOI": "10.1016/j.ijpharm.2006.02.027",
      "article-title": "A folate receptor-targeted liposomal formulation for paclitaxel",
      "volume": "316",
      "author": "Wu",
      "year": "2006",
      "journal-title": "Int. J. Pharm."
    },
    {
      "key": "10.1016/j.addr.2008.08.005_bib114",
      "series-title": "Cancer Facts & Figures 2008",
      "author": "Society",
      "year": "2008"
    },
    {
      "issue": "3",
      "key": "10.1016/j.addr.2008.08.005_bib115",
      "doi-asserted-by": "crossref",
      "first-page": "209",
      "DOI": "10.1016/j.jconrel.2008.03.010",
      "article-title": "Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy",
      "volume": "128",
      "author": "Chen",
      "year": "2008",
      "journal-title": "J. Control. Release"
    },
    {
      "issue": "28",
      "key": "10.1016/j.addr.2008.08.005_bib116",
      "doi-asserted-by": "crossref",
      "first-page": "4975",
      "DOI": "10.1016/j.biomaterials.2006.05.016",
      "article-title": "Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells",
      "volume": "27",
      "author": "Steinhauser",
      "year": "2006",
      "journal-title": "Biomaterials"
    },
    {
      "issue": "8",
      "key": "10.1016/j.addr.2008.08.005_bib117",
      "doi-asserted-by": "crossref",
      "first-page": "1565",
      "DOI": "10.1016/j.biomaterials.2006.11.018",
      "article-title": "Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference",
      "volume": "28",
      "author": "Tan",
      "year": "2007",
      "journal-title": "Biomaterials"
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib118",
      "doi-asserted-by": "crossref",
      "first-page": "352",
      "DOI": "10.1016/j.jcis.2004.09.042",
      "article-title": "Surface modification of monodisperse magnetite nanoparticles for improved intracellular uptake to breast cancer cells",
      "volume": "283",
      "author": "Zhang",
      "year": "2005",
      "journal-title": "J. Colloid Interface Sci."
    },
    {
      "issue": "17",
      "key": "10.1016/j.addr.2008.08.005_bib119",
      "doi-asserted-by": "crossref",
      "first-page": "2663",
      "DOI": "10.1016/j.biomaterials.2008.02.020",
      "article-title": "Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles",
      "volume": "29",
      "author": "Pan",
      "year": "2008",
      "journal-title": "Biomaterials"
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib120",
      "doi-asserted-by": "crossref",
      "first-page": "163",
      "DOI": "10.1007/s10549-006-9199-7",
      "article-title": "LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases",
      "volume": "99",
      "author": "Leuschner",
      "year": "2006",
      "journal-title": "Breast Cancer Res. Treat."
    },
    {
      "issue": "5",
      "key": "10.1016/j.addr.2008.08.005_bib121",
      "doi-asserted-by": "crossref",
      "first-page": "437",
      "DOI": "10.1016/S1476-5586(03)80046-5",
      "article-title": "Isolation of a colon tumor specific binding peptide using phage display selection",
      "volume": "5",
      "author": "Kelly",
      "year": "2003",
      "journal-title": "Neoplasia"
    },
    {
      "issue": "6",
      "key": "10.1016/j.addr.2008.08.005_bib122",
      "doi-asserted-by": "crossref",
      "first-page": "705",
      "DOI": "10.2217/14796694.2.6.705",
      "article-title": "Opportunities for near-infrared thermal ablation of colorectal metastases by guanylyl cyclase C-targeted gold nanoshells",
      "volume": "2",
      "author": "Waldman",
      "year": "2006",
      "journal-title": "Future Oncol."
    },
    {
      "issue": "4",
      "key": "10.1016/j.addr.2008.08.005_bib123",
      "doi-asserted-by": "crossref",
      "first-page": "145",
      "DOI": "10.1016/j.tibtech.2007.02.005",
      "article-title": "Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer",
      "volume": "25",
      "author": "Fortina",
      "year": "2007",
      "journal-title": "Trends Biotech."
    },
    {
      "issue": "20",
      "key": "10.1016/j.addr.2008.08.005_bib124",
      "doi-asserted-by": "crossref",
      "first-page": "10048",
      "DOI": "10.1158/0008-5472.CAN-06-1605",
      "article-title": "Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors",
      "volume": "66",
      "author": "Koizumi",
      "year": "2006",
      "journal-title": "Cancer Res."
    },
    {
      "issue": "9",
      "key": "10.1016/j.addr.2008.08.005_bib125",
      "doi-asserted-by": "crossref",
      "first-page": "2148",
      "DOI": "10.1002/ijc.23381",
      "article-title": "Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil",
      "volume": "122",
      "author": "Nakajima",
      "year": "2008",
      "journal-title": "Int. J. Cancer"
    },
    {
      "issue": "7",
      "key": "10.1016/j.addr.2008.08.005_bib126",
      "doi-asserted-by": "crossref",
      "first-page": "1240",
      "DOI": "10.1038/sj.bjc.6602479",
      "article-title": "NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel",
      "volume": "92",
      "author": "Hamaguchi",
      "year": "2005",
      "journal-title": "Br. J. Cancer"
    },
    {
      "issue": "10",
      "key": "10.1016/j.addr.2008.08.005_bib127",
      "doi-asserted-by": "crossref",
      "first-page": "1558",
      "DOI": "10.1023/A:1026170830782",
      "article-title": "Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs",
      "volume": "20",
      "author": "Jel\u00ednkov\u00e1",
      "year": "2003",
      "journal-title": "Pharm. Res."
    },
    {
      "key": "10.1016/j.addr.2008.08.005_bib128",
      "series-title": "Cancer Facts & Figures 2008",
      "author": "Society",
      "year": "2008"
    },
    {
      "issue": "2",
      "key": "10.1016/j.addr.2008.08.005_bib129",
      "doi-asserted-by": "crossref",
      "first-page": "328",
      "DOI": "10.1016/j.bbrc.2005.05.132",
      "article-title": "Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy",
      "volume": "333",
      "author": "Ferrara",
      "year": "2005",
      "journal-title": "Biochem. Biophys. Res. Commun."
    },
    {
      "issue": "6",
      "key": "10.1016/j.addr.2008.08.005_bib130",
      "doi-asserted-by": "crossref",
      "first-page": "991",
      "DOI": "10.1002/cmdc.200800030",
      "article-title": "Molecular recognition of small-cell lung cancer cells using aptamers",
      "volume": "3",
      "author": "Chen",
      "year": "2008",
      "journal-title": "Chem. Med. Chem."
    },
    {
      "issue": "27",
      "key": "10.1016/j.addr.2008.08.005_bib131",
      "doi-asserted-by": "crossref",
      "first-page": "3996",
      "DOI": "10.1016/j.biomaterials.2007.05.006",
      "article-title": "Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting",
      "volume": "28",
      "author": "Tseng",
      "year": "2007",
      "journal-title": "Biomaterials"
    },
    {
      "issue": "5",
      "key": "10.1016/j.addr.2008.08.005_bib132",
      "doi-asserted-by": "crossref",
      "first-page": "579",
      "DOI": "10.1021/mp060039w",
      "article-title": "Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells",
      "volume": "3",
      "author": "Li",
      "year": "2006",
      "journal-title": "Mol. Pharmacol."
    },
    {
      "issue": "1",
      "key": "10.1016/j.addr.2008.08.005_bib133",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1196/annals.1348.001",
      "article-title": "Surface-modified LPD nanoparticles for tumor targeting",
      "volume": "1082",
      "author": "Li",
      "year": "2006",
      "journal-title": "Ann. N. Y. Acad. Sci."
    },
    {
      "issue": "1",
      "key": "10.1016/j.addr.2008.08.005_bib134",
      "first-page": "81",
      "article-title": "Prostate-specific membrane antigen expression in normal and malignant human tissues",
      "volume": "3",
      "author": "Silver",
      "year": "1997",
      "journal-title": "Clin. Cancer Res."
    },
    {
      "issue": "48",
      "key": "10.1016/j.addr.2008.08.005_bib135",
      "doi-asserted-by": "crossref",
      "first-page": "8149",
      "DOI": "10.1002/anie.200602251",
      "article-title": "An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform",
      "volume": "45",
      "author": "Bagalkot",
      "year": "2006",
      "journal-title": "Angew. Chem., Int. Ed. Engl."
    },
    {
      "issue": "5",
      "key": "10.1016/j.addr.2008.08.005_bib136",
      "doi-asserted-by": "crossref",
      "first-page": "869",
      "DOI": "10.1016/j.biomaterials.2006.09.047",
      "article-title": "Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery",
      "volume": "28",
      "author": "Cheng",
      "year": "2007",
      "journal-title": "Biomaterials"
    },
    {
      "issue": "16",
      "key": "10.1016/j.addr.2008.08.005_bib137",
      "doi-asserted-by": "crossref",
      "first-page": "6315",
      "DOI": "10.1073/pnas.0601755103",
      "article-title": "Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo",
      "volume": "103",
      "author": "Farokhzad",
      "year": "2006",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "issue": "21",
      "key": "10.1016/j.addr.2008.08.005_bib138",
      "doi-asserted-by": "crossref",
      "first-page": "7668",
      "DOI": "10.1158/0008-5472.CAN-04-2550",
      "article-title": "Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells",
      "volume": "64",
      "author": "Farokhzad",
      "year": "2004",
      "journal-title": "Cancer Res."
    },
    {
      "issue": "3",
      "key": "10.1016/j.addr.2008.08.005_bib139",
      "doi-asserted-by": "crossref",
      "first-page": "311",
      "DOI": "10.1517/17425247.3.3.311",
      "article-title": "Nanoparticle-aptamer bioconjugates for cancer targeting",
      "volume": "3",
      "author": "Farokhzad",
      "year": "2006",
      "journal-title": "Expert Opin. Drug Deliv."
    },
    {
      "issue": "9",
      "key": "10.1016/j.addr.2008.08.005_bib140",
      "first-page": "1445",
      "article-title": "Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells",
      "volume": "2",
      "author": "Pinto",
      "year": "1996",
      "journal-title": "Clin. Cancer Res."
    },
    {
      "issue": "1",
      "key": "10.1016/j.addr.2008.08.005_bib141",
      "doi-asserted-by": "crossref",
      "first-page": "173",
      "DOI": "10.1016/j.jconrel.2004.03.007",
      "article-title": "Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer",
      "volume": "97",
      "author": "Hattori",
      "year": "2004",
      "journal-title": "J. Control. Release"
    },
    {
      "issue": "10",
      "key": "10.1016/j.addr.2008.08.005_bib142",
      "doi-asserted-by": "crossref",
      "first-page": "796",
      "DOI": "10.1038/sj.cgt.7700844",
      "article-title": "Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase",
      "volume": "12",
      "author": "Hattori",
      "year": "2005",
      "journal-title": "Cancer Gene Ther."
    },
    {
      "issue": "4",
      "key": "10.1016/j.addr.2008.08.005_bib143",
      "doi-asserted-by": "crossref",
      "first-page": "693",
      "DOI": "10.1002/ijc.20452",
      "article-title": "Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells",
      "volume": "112",
      "author": "Banerjee",
      "year": "2004",
      "journal-title": "Int. J. Cancer"
    }
  ],
  "container-title": "Advanced Drug Delivery Reviews",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0169409X08002251?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0169409X08002251?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        20
      ]
    ],
    "date-time": "2023-05-20T01:24:46Z",
    "timestamp": 1684545886000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0169409X08002251"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2008,
        12
      ]
    ]
  },
  "references-count": 143,
  "journal-issue": {
    "issue": "15",
    "published-print": {
      "date-parts": [
        [
          2008,
          12
        ]
      ]
    }
  },
  "alternative-id": [
    "S0169409X08002251"
  ],
  "URL": "http://dx.doi.org/10.1016/j.addr.2008.08.005",
  "relation": {},
  "ISSN": [
    "0169-409X"
  ],
  "subject": [],
  "container-title-short": "Advanced Drug Delivery Reviews",
  "published": {
    "date-parts": [
      [
        2008,
        12
      ]
    ]
  }
}